Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • BridgeBio emerges from stealth mode

    BridgeBio, which was formed in 2015, emerged from stealth mode. The company will focus on developing precision medicine to treat genetic diseases. The company plans to form subsidiaries focused on individual assets or …

    Published on 1/23/2017
  • Dynavax restructuring news

    Dynavax will reduce headcount by 100 (38%) to 164 and will focus on its immuno-oncology pipeline. The company said the cuts would come from manufacturing support and SG&A positions. SD-101, an immunostimulatory …

    Published on 1/23/2017
  • NICE financial news

    The U.K.'s NICE said it will delay its plan to recover appraisal costs of drugs, medical devices and diagnostics until the U.K. government finishes its life sciences strategy. NICE had planned to charge companies for …

    Published on 1/23/2017
  • American Association for Cancer Research genomics news

    AACR released a set of cancer genomic data through its Genomics Evidence Neoplasia Information Exchange (GENIE) initiative. The data set includes 19,000 de-identified genomic records for 59 major cancer types.The data …

    Published on 1/16/2017
  • iCarbonX Digital Life Alliance news

    iCarbonX said seven companies joined its Digital Life Alliance, through which it aims to combine genetic, biologic and patient-generated data with sequencing and artificial intelligence technology to "instantly detect …

    Published on 1/16/2017
  • iCarbonX launches Meum platform

    iCarbonX launched its Meum database and health management platform with several companies from its iCarbonX ecosystem. iCarbonX said Meums database includes data on genetics, molecular profiles, phenotypes and behavior.…

    Published on 1/16/2017
  • J&J, New York Genome Center deal

    The Johnson & Johnson Innovation LLC subsidiary of Johnson & Johnson launched JLABS @ NYC, a JLABS incubator in New York City. The facility, slated to open in 2018, was launched in collaboration with New York …

    Published on 1/16/2017
  • Alexion clarifies 10-Q accounting

    Alexion filed a delayed 10-Q for 3Q16 and revealed that it would not need to restate previously issued financial results. The Audit and Finance Committee of Alexion's board did determine that some Soliris eculizumab …

    Published on 1/9/2017
  • Amgen, Regeneron, Sanofi endocrine/metabolic news

    A federal judge granted Amgen a permanent injunction banning U.S. sales of rival cholesterol-lowering drug Praluent alirocumab from Regeneron and Sanofi, citing irreparable harm due to infringement of patents protecting…

    Published on 1/9/2017
  • Emergent BioSolutions infectious news

    Emergent signed a follow-on contract with the CDC worth up to $911 million to supply 29.4 million doses of BioThrax to the U.S. Strategic National Stockpile through September 2021. BioThrax is approved for pre-or post-…

    Published on 1/9/2017
  • OvaScience endocrine/metabolic news

    OvaScience will reduce headcount by about 30% and slow commercial expansion of its Augment fertility treatment to extend its cash runway into 1Q19. In connection with the restructuring, President and CEO Harald Stock …

    Published on 1/9/2017
  • Amgen, Apotex, Novartis biosimilars news

    The U.S. Supreme Court denied a petition from Apotex asking SCOTUS to review a lower court ruling barring Apotex from launching its biosimilar version of Amgens neutropenia drug Neulasta pegfilgrastim until 180 days …

    Published on 1/2/2017
  • CRISPR companies team up to defend IP

    The companies announced a cross-licensing and invention management agreement regarding the foundational CRISPR/Cas9 IP each has licensed or sublicensed from the University of California Berkeley (Berkeley, Calif.), the …

    Published on 1/2/2017
  • Kite, Memorial Sloan Kettering cancer news

    The U.S. Patent and Trademark Office (PTO) upheld the validity of U.S. Patent No. 7,446,190 from Memorial Sloan Kettering Cancer Center covering chimeric antigen receptors (CAR) and their method of use as cancer …

    Published on 1/2/2017
  • Lilly joins cTAP consortium

    The Collaborative Trajectory Analysis Project (cTAP) said Eli Lilly has joined the consortium. The group, which includes scientists, drug companies, patient advocacy organizations and clinical centers, is collaborating …

    Published on 1/2/2017
  • Boehringer Ingelheim pharmaceuticals news

    Boehringer said it began reducing headcount as of July 1 by about 244 nationwide. The reduction includes about 120 in its small molecule discovery research division. The company said it will consolidate the division to …

    Published on 12/19/2016
  • Gilead, Merck infectious news

    A federal jury ordered Gilead to pay Merck $2.5 billion in damages in an HCV patent infringement lawsuit. According to the jury's verdict, the damages are based on a 10% royalty rate for Gilead's U.S. sales for Sovaldi …

    Published on 12/19/2016
  • Themis, EVI, Institut Pasteur and the CEA form Zika consortium

    Themis, EVI, Institut Pasteur and the CEA formed the Zikavax Consortium to develop a vaccine to prevent Zika virus infection. The consortium received 5 million ($5.3 million) in funding from the EUs Horizon 2020 program…

    Published on 12/19/2016
  • Orexo, Allergan neurology news

    The U.S. District Court for the District of Delaware ruled that U.S. Patent No. 8,454,996 covering Orexo's Zubsolv buprenorphine/naloxone (OX219) is valid and infringed by Allergan's ANDA for a generic version of …

    Published on 12/12/2016
  • Otsuka neurology news

    Otsuka's Astex Pharmaceuticals Inc. subsidiary joined the Dementia Discovery Fund as an investor. The U.K. government launched the fund last year to support dementia research, with an initial $100 million in funding …

    Published on 12/12/2016
  • SRI International, NIH cancer news

    NIHs National Institute of Allergy and Infectious Diseases and Division of AIDS (NIAID-DAIDS) awarded a seven-year contract of up to $150 million to SRI to provide services to support development of HIV microbicides and…

    Published on 12/12/2016
  • ASCO and others release HER2 and other cancer treatment guidance

    The College of American Pathologists, the American Society for Clinical Pathology and the American Society of Clinical Oncology published an evidence-based guideline on HER2 testing for patients with gastroesophageal …

    Published on 12/5/2016
  • Orchard, UCLA receive CIRM grant

    CIRM awarded Orchard and researchers from the university a $20 million grant to fund a clinical trial of an autologous ex vivo lentiviral gene therapy to treat severe combined immunodeficiency due to adenosine deaminase…

    Published on 12/5/2016
  • TESLA initiative launches

    The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute partnered to improve algorithms used to identify cancer neoantigens. Nonprofit organization Sage Bionetworks (Seattle, Wash.) will manage …

    Published on 12/5/2016
  • Alexion Soliris eculizumab news

    Alexion said it was delaying its 3Q16 10-Q filing while it investigates a former employee's allegations that company personnel engaged in sales practices "inconsistent" with Alexion's policies. The allegations concern …

    Published on 11/21/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993